ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CELZ vs CRIS // EV/EBITDA & P/E VALUATION

Creative Medical Technology Holdings Inc. (NASDAQ) VS. Curis Inc. (NASDAQ) • 15-METRIC TALLY: CELZ 2 — CRIS 2
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CELZ VS. CRIS) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CELZ CRIS SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 63.40% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -35.00% -35.00% 0.00 TIE /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) -45.50% -13.40% -32.10 CRIS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 0.20 — — TIE /balance-sheet <GO>
Piotroski F-Score Quality 3/9 1/9 +2.00 CELZ /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 31.7 42.2 -10.45 CRIS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.2M $3.7M $1.5M CELZ /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CELZ REV CRIS REV CELZ GROSS % CRIS GROSS % CELZ FCF CRIS FCF
FY 2025 $6.0K $9.4M 63.4% — -$5.9M -$27.2M
FY 2024 $11.0K $10.9M 60.0% — -$5.3M -$39.6M
FY 2023 $9.0K $10.0M — — -$8.0M -$38.4M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CELZ // BETA —
CRIS // BETA —